Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2010
09/23/2010WO2010107040A1 Solid preparation containing npy y5 receptor antagonist
09/23/2010WO2010106981A1 Base material for spraying comprising low-molecular gelling agent
09/23/2010WO2010106936A1 Orally disintegrating tablet
09/23/2010WO2010106571A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
09/23/2010WO2010106555A2 Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
09/23/2010WO2010106502A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it
09/23/2010WO2010106465A1 A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
09/23/2010WO2010106459A1 A dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate
09/23/2010WO2010106313A1 Improvement in solubility of drugs by means of hyaluronic acid
09/23/2010WO2010106191A1 Pharmaceutical composition presenting anti-inflammatory properties
09/23/2010WO2010106095A1 In situ constituting a vaccine for administration to a predetermined herd of animals
09/23/2010WO2010106063A2 Composite materials loaded with therapeutic and diagnostic agents comprising polymer nanoparticles and polymer fibers
09/23/2010WO2010106050A1 A particle stabilised oil-in-water emulsion
09/23/2010WO2010106046A1 Macrocyclic lactone drug delivery system
09/23/2010WO2010105995A2 Zoo-technical drug delivery device
09/23/2010WO2010105991A1 Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
09/23/2010WO2010105842A2 Preparation for external application
09/23/2010WO2010105824A1 Retigabine tablets, preferably having modified release
09/23/2010WO2010105823A1 Solid retigabine in non-crystalline form
09/23/2010WO2010105822A2 Dry processing of retigabine
09/23/2010WO2010105673A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
09/23/2010WO2010105672A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
09/23/2010WO2010105448A1 A chinese medicinal composition for external use in treatment and health care of renal function and its use in manufacture of cataplasm
09/23/2010WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression
09/23/2010WO2010105342A1 Transdermal pharmaceutical preparation and administration of tirofiban
09/23/2010WO2010088537A3 Improved lipid formulation for the delivery of nucleic acids
09/23/2010WO2010081722A3 Orally disintegrating tablets for the treatment of pain
09/23/2010WO2010065563A3 Apratoxin therapeutic agents: mechanism and methods of treatment
09/23/2010WO2010065069A3 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
09/23/2010WO2010062824A3 Enhanced bioactive formulations of resveratrol
09/23/2010WO2010058297A9 The use of ph-sensitive, acid-stable metal-binding nanoparticles
09/23/2010WO2010038091A3 Compositions comrrising amlodipine and bisoprolol
09/23/2010WO2010033800A3 Stable tetracycline aqueous formulations
09/23/2010WO2010031720A3 Novel antibody formulation
09/23/2010WO2010004018A3 Degradable microcapsules
09/23/2010WO2009135948A3 Process for preparing a high drug load tablet
09/23/2010WO2009100716A3 Implantable products comprising nanoparticles
09/23/2010WO2009097332A3 Therapeutic compositions comprising an amine-containing lipid and a protein
09/23/2010US20100241219 Medicament delivery article, accessory & system
09/23/2010US20100240899 when the plasma nicotinic acid or nicotinuric acid curves are deconvoluted using the Wagner-Nelson method; side effect reduction
09/23/2010US20100240771 Process for preparing aqueous-alcoholic solution and products based thereon
09/23/2010US20100240761 Bronchodilating beta-agonist compositions and methods
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100239686 Method For Making Nanolipidic Particles
09/23/2010US20100239685 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same
09/23/2010US20100239684 Granular jelly beverage for medication and process for producing the same
09/23/2010US20100239683 Sustained release of microcrystalline peptide suspensions
09/23/2010US20100239682 Colonic delivery of antimicrobial agents
09/23/2010US20100239681 Controlled Release Particulates Containing Water-Insoluble Drug
09/23/2010US20100239680 Powder Cosmetic Composition
09/23/2010US20100239678 Ionically functionalized nanodiamonds
09/23/2010US20100239677 Nonaerosol/aerosol dispensing of sunscreen sprays comprising silica microparticles
09/23/2010US20100239676 Stable Aerosolizable Suspensions of Proteins in Ethanol
09/23/2010US20100239675 Plasmon mediated photoinduced synthesis of silver triangular bipyramids
09/23/2010US20100239674 Pharmaceutical composition for the treatment and prevention of diseases involving impotence
09/23/2010US20100239673 Blood compatible nanomaterials and methods of making and using the same
09/23/2010US20100239672 Layer silicate nanocomposites of polymer hydrogels and their use in tissue expanders
09/23/2010US20100239671 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
09/23/2010US20100239670 Topical Composition Method for Treating Urinary Stress Incontinence
09/23/2010US20100239669 Combinations of statins and anti-obesity agent
09/23/2010US20100239668 Segmented pharmaceutical dosage forms
09/23/2010US20100239667 Controlled release pharmaceutical compositions for prolonged effect
09/23/2010US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
09/23/2010US20100239665 Pharmaceutical nimodipine compositions
09/23/2010US20100239664 Forms of rifaximin and uses thereof
09/23/2010US20100239663 Composition for foodstuff for binding acetaldehyde
09/23/2010US20100239662 Misuse preventative, controlled release formulation
09/23/2010US20100239661 Pharmaceutical compositions of ursodiol
09/23/2010US20100239660 Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions
09/23/2010US20100239659 Self-assembling amphiphilic polymers as anti-cancer agents
09/23/2010US20100239658 Gallium nitrate formulations
09/23/2010US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs
09/23/2010US20100239656 Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
09/23/2010US20100239655 Taurine-based compositions and therapeutic methods
09/23/2010US20100239654 Vesicular phospholipid gels comprising proteinaceous substances
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239652 Immunoliposomes for treatment of cancer
09/23/2010US20100239650 Isothiazolin biodelivery systems
09/23/2010US20100239649 Tumor Suppressor Factor
09/23/2010US20100239648 Self-locating, multiple application, and multiple location medical patch systems and methods therefor
09/23/2010US20100239647 Photoresponsive ionogel
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239645 Methods and Compositions for Wound Healing
09/23/2010US20100239643 Anti-itch sheet
09/23/2010US20100239642 Coating compositions
09/23/2010US20100239641 Warming vapor pad
09/23/2010US20100239640 Skin-derived precursor cells and uses thereof
09/23/2010US20100239639 Medicated patch
09/23/2010US20100239638 Chewable soft capsule having improved ingestion property and method for producing same
09/23/2010US20100239637 Contact lens drug delivery device
09/23/2010US20100239635 Drug delivery medical device
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239632 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239621 Gel sheet and cosmetic preparation in sheet form using the same
09/23/2010US20100239617 Modified rsv f proteins and methods of their use
09/23/2010US20100239616 Controlled activation ingestible identifier
09/23/2010US20100239524 Microparticles prepared using an ionic liquid
09/23/2010US20100239513 Aqueous compositions comprising vesicles having certain vesicle permeability
09/23/2010US20100239507 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles